Vita Imaging

Vita Imaging is a medical-device company developing cancer detection and diagnostic technology.

Skin cancer is the most common cancer in the U.S. Nearly 10,000 Americans are diagnosed with the disease every day, and one in five will develop skin cancer in their lifetime.

Vita's patented AURA device can identify skin cancer in less than two seconds — the result of twenty years of research & development and more than twenty million dollars in investment.

FDA approval for Vita's device is pending and the company has completed peer-reviewed studies at Harvard and the University of British Columbia.

Team Background

Thinh Tran - Chairman and CEO

Thinh has extensive experience growing businesses.

Prior to Vita Imaging, he was Chairman and CEO of V-Silicon, a leader in the smart-television market. Before that, he founded Sigma Designs, a semiconductor-manufacturing company that went public.

Earlier in his career, Thinh worked for Amdahl Corporation and Trilogy Systems Corporation, two computer-technology companies. He earned a Bachelor’s degree in Electrical and Electronics Engineering from the University of Wisconsin and a Master’s degree in Electrical Engineering from Stanford.

Maria Reade - Chief Operating Officer

Maria has a background in developing biotech-related therapeutics.

Prior to joining Vita Imaging, she was Head of Clinical and Business Operations with Quest Clinical Research, a biotech company researching infectious diseases and diabetes. Before that, she was a consultant with DaVinci Consulting, a company serving biotech-related businesses.

Earlier, she was Chief Administrative Officer with College Medical Center, a California-based healthcare company. Before that, she founded iontherapeutics, a medical-device startup that achieved FDA approval for devices aimed at treating diabetes.

Maria holds a Bachelor’s degree in Nursing from the University of Tennessee and an MBA from Pace University.

Co-Investors